Publications
Print PDF
Amgen, Sanofi’s Cholesterol Drug Spat a Turning Point on Patents
December 27, 2019
Valerie Bauman
Bloomberg Law

Axinn partner Aziz Burgy was quoted in the Bloomberg Law article, "Amgen, Sanofi’s Cholesterol Drug Spat a Turning Point on Patents."

Click here to access the article. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.